Peter Zdziarski: Increasing Investment Activity, Data Generation, and Implications for Patient Access to Glanzmann Thrombasthenia
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:
“I always track what’s trending with Glanzmann Thrombasthenia so I can keep our community informed on the latest studies, news, and research.
Lately, a lot of what I’m seeing is centered around multiple companies in the space going public or moving in that direction.
On one side, that’s exciting. More investment can move research forward.
But it can also bring pressure to show growth.
In GT, that can mean more data collection, more sponsored content targeting our community, and stronger attempts to shape the narrative toward the negatives of living with a rare disease.
There’s also the concern around pricing. When new treatments do come, will access be prioritized, or will profits?
Of course, I hope I’m wrong. And I hope to start seeing more stories of patients living, adapting, and succeeding trending again soon for GT.”
More posts featuring Peter Zdziarski on Hemostasis Today.
-
May 11, 2026, 16:52Luke McLaughlin: Raising Awareness on Haemophilia Issues at ENIL Lead On
-
May 11, 2026, 16:49Jeff Sternlicht: Normal LDL Does Not Always Mean Low Risk
-
May 11, 2026, 16:42Archil Jaliashvili: From Managing Blood to Managing Oxygen Metabolism
-
May 11, 2026, 16:42Heghine Khachatryan: Celebrating One Hundred Years of von Willebrand Disease with EHC
-
May 11, 2026, 16:34Jane Hankins: Excited to Have Been a Part of the Faculty of ASH CRTI LA
-
May 11, 2026, 16:28Conan McIlwrath at the Rare Bleeding Disorders Conference Representing The Haemophilia Society as Chair
-
May 11, 2026, 16:24Anna A. Avagyan: Presenting Armenia’s Experience at SIOP Europe 2026
-
May 11, 2026, 16:18Mohamed Elkhider: Raising Awareness on Aortic Dissection
-
May 11, 2026, 16:11David McIntosh: A Pensioner’s Reflections on Blood Donation